Doç. Dr. Özgen Ahmet Yıldırım
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Carcinoma, Non-Small-Cell Lung 2 publications
- Lung Neoplasms 2 publications
- COVID-19 2 publications
- Neoplasms 2 publications
- Prostatic Neoplasms 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologysaglik.gov.trFrom source
- InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
- Area of workBreast NeoplasmsExtracted from 3 publications · Model version —From source
- Publications38 publicationsORCID, Europe PMC, OpenAlexFrom source
- ORCID0000-0002-4139-067XORCIDFrom source
- Last synchronised7 November 2026 00:02https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#ozgen-ahmet-yildirimsaglik.gov.tr
Scientific work
Publications on Breast Neoplasms
-
Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study
Medicina, 2026
DOI 10.3390/medicina62040763 PMID 42075632 Open-access full textSource: ORCID
-
Level II (IIA/IIB) Lymph Node Evaluation in Head and Neck Cancer: A Retrospective Cohort Study from a Non-Endemic Region
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15031068 PMID 41682748 Open-access full textSource: ORCID
-
Exploring the impacts of docetaxel and paclitaxel based neoadjuvant therapies on early postoperative complications in HER2-positive breast cancer patients
World journal of surgical oncology, 2026
DOI 10.1186/s12957-026-04434-z PMID 42192428 Open-access full textSource: Europe PMC
-
Claudin 18.2 Positivity Thresholds and Candidate Populations for Targeted Therapy in Pancreatic Ductal Adenocarcinoma: A Real-World Retrospective Cohort
Cancers, 2026
DOI 10.3390/cancers18172827 PMID 42738347 Open-access full textSource: OpenAlex
-
Structural Acceleration in Sepsis-Associated Cancer Mortality in an Aging Population: A Nationwide Study in the United States, 1999–2020
SSRN Electronic Journal, 2026
DOI 10.2139/ssrn.6201853 Open-access full textSource: OpenAlex
-
Hepatocellular carcinoma in Turkey: A nationwide health system database analysis of clinical patterns and survival
Cancer Epidemiology, 2026
DOI 10.1016/j.canep.2026.103255 PMID 42887435 Source: ORCID
-
The Role of Dominant Lesion Site and SUVmax in the Depth of PSA Response in Metastatic Hormone-Sensitive Prostate Cancer
Biomedicines, 2026
DOI 10.3390/biomedicines14102160 PMID 42939968 Open-access full textSource: ORCID
-
Proton Pump Inhibitor Use and Survival Outcomes in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Immunotherapy: A Real-World Study
Medicina, 2026
DOI 10.3390/medicina62071413 PMID 42512955 Open-access full textSource: ORCID
-
Impact of COVID-19 Vaccine Type on the Efficacy and Safety of Nivolumab in Patients With Metastatic Non-small-cell Lung Cancer: A Multicenter Study
In Vivo, 2026
DOI 10.21873/invivo.14401 PMID 42379805 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Hospitalized oncology patients with diarrhea: Clinical outcomes and prognostic factors.
Journal of Clinical Oncology, 2026
DOI 10.1200/jco.2026.44.16_suppl.11136 Source: OpenAlex